|
|
|
Volumn 307, Issue 5716, 2005, Pages 1708-
|
|
More woes for novel HIV prevention approach
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIAMORPHINE;
METHADONE;
TENOFOVIR;
ADENINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DRUG DERIVATIVE;
PHOSPHONIC ACID DERIVATIVE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
DRUG USE;
HIGH RISK POPULATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION PREVENTION;
INSTRUMENT STERILIZATION;
MEDICAL ETHICS;
NOTE;
PRIORITY JOURNAL;
PROPHYLAXIS;
SCREENING;
SEXUAL BEHAVIOR;
SIDE EFFECT;
ARTICLE;
ETHICS;
NIGERIA;
PATIENT SELECTION;
PROSTITUTION;
PUBLIC HEALTH SERVICE;
STANDARD;
SUBSTANCE ABUSE;
THAILAND;
UNITED STATES;
ADENINE;
ANTI-HIV AGENTS;
CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.);
CLINICAL TRIALS;
HIV INFECTIONS;
HUMANS;
NIGERIA;
PATIENT SELECTION;
PHOSPHONIC ACIDS;
PROSTITUTION;
SUBSTANCE ABUSE, INTRAVENOUS;
THAILAND;
UNITED STATES;
|
|
EID: 15544368043
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|